Thomas Catinazzo Relay Therapeutics, Inc. (RLAY) insider trading activity

Thomas Catinazzo is Chief Financial Officer of Relay Therapeutics, Inc.. Currently has a direct ownership of 304,091 shares of RLAY, which is worth approximately $1.44 Million. The most recent transaction as insider was on Apr 28, 2022, when has been sold 725 shares (Common Stock) at a price of $25.57 per share, resulting in proceeds of $18,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 304K

4.87% 3M change

110.96% 12M change

Total Value Held $1.44 Million

Thomas Catinazzo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2022	SELL Open market or private sale	$18,538 $25.57 p/Share	725 Reduced 1.34%	53,252 Common Stock
Mar 29 2022	SELL Open market or private sale	$8,423 $29.87 p/Share	282 Reduced 0.52%	53,977 Common Stock
Mar 24 2022	SELL Open market or private sale	$398,580 $30.0 p/Share	13,286 Reduced 19.67%	54,259 Common Stock
Mar 24 2022	BUY Exercise of conversion of derivative security	$54,738 $4.12 p/Share	13,286 Added 16.44%	67,545 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	39,270 Added 41.99%	54,259 Common Stock
Dec 27 2021	SELL Open market or private sale	$9,764 $33.1 p/Share	295 Reduced 1.93%	14,989 Common Stock
Nov 15 2021	SELL Open market or private sale	$796,500 $35.4 p/Share	22,500 Reduced 59.55%	15,284 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$92,700 $4.12 p/Share	22,500 Added 37.32%	37,784 Common Stock
Sep 27 2021	SELL Open market or private sale	$10,803 $36.87 p/Share	293 Reduced 1.88%	15,284 Common Stock
Sep 13 2021	SELL Open market or private sale	$787,500 $35.0 p/Share	22,500 Reduced 59.09%	15,577 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$92,700 $4.12 p/Share	22,500 Added 37.14%	38,077 Common Stock
Jun 28 2021	SELL Open market or private sale	$10,492 $35.81 p/Share	293 Reduced 1.85%	15,577 Common Stock
Jun 07 2021	SELL Open market or private sale	$787,500 $35.0 p/Share	22,500 Reduced 58.64%	15,870 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$92,700 $4.12 p/Share	22,500 Added 36.96%	38,370 Common Stock
Mar 30 2021	SELL Open market or private sale	$787,500 $35.0 p/Share	22,500 Reduced 100.0%	0 Common Stock
Mar 30 2021	BUY Exercise of conversion of derivative security	$92,700 $4.12 p/Share	22,500 Added 50.0%	22,500 Common Stock
Mar 26 2021	BUY Grant, award, or other acquisition	-	15,870 Added 50.0%	15,870 Common Stock

Thomas Catinazzo

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Value

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Relay Therapeutics, Inc.

Track Activities on RLAY

Account